Compare Brevis (BREV) vs Symbiosis (SIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Brevis vs Symbiosis — how do they compare? Brevis trades at Rp1,315 (market cap Rp330,38M, Rp228,73M 24h volume), while Symbiosis trades at Rp293.08 (market cap Rp34,08M, Rp2,71M 24h volume). The key difference: Brevis is far larger — about 9.7× Symbiosis's market cap, and Brevis's circulating supply is 250M / 1B BREV (25%) versus 97M / 99,5M SIS (98%) for Symbiosis. Which is the better fit depends on your goals — on Pluang, investors hold Brevis for 6 Days and Symbiosis for 12 Days on average.
| BREV | SIS | |
|---|---|---|
Market Cap | Rp330,38M | Rp34,08M |
Volume (24h) | Rp228,73M | Rp2,71M |
Circulating Supply | 250M / 1B BREV (25%) | 97M / 99,5M SIS (98%) |
Typical Hold Time | 6 Days | 12 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Brevis (BREV) shows mixed technical signals with an overall bullish bias despite bearish moving averages. The token trades at Rp1,345.9 with a market cap of Rp333.86 million and 25% circulating supply. Key technical indicators show RSI_6 at 27.08 (oversold) and strong ADX readings suggesting trending momentum. Support levels are established at Rp1,256-Rp1,335 while resistance sits at Rp1,413-Rp1,492.
Overall outlook suggests cautious optimism with oversold RSI signaling potential rebound. Key opportunities include technical bounce from support levels, while major risks involve limited liquidity (Rp333.86M market cap) and absence of recent protocol updates. Investors should monitor volume confirmation for sustained moves.
Symbiosis (SIS) is a cryptocurrency with a market cap of Rp34.08 million and a high circulation rate of 98%, indicating most tokens are in the market. The token has a max supply of 99.5 million SIS, with 97 million currently circulating. Hold time is relatively short at 12 days, suggesting active trading. No recent protocol updates or ecosystem developments were found.
Outlook: SIS presents a micro-cap opportunity with high liquidity due to near-full circulation, but faces significant risks from low market cap volatility and lack of recent developments. Key risks include price instability and limited exchange liquidity, while the opportunity lies in potential ecosystem growth if adoption increases.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Brevis
Brevis is a verifiable computing platform that enables scalable, trustless computation across blockchain, data, and AI systems. It allows complex programs and data queries to run off-chain and be verified on-chain using zero-knowledge proofs, delivering significantly lower costs and latency while preserving security and trustlessness.
Read more on BREV →About Symbiosis
Symbiosis is a platform for cross-chain swaps that eliminates the need for multiple transactions. It aggregates liquidity from various Automated Market Makers (AMMs) and Decentralized Exchanges (DEXs) across EVM and non-EVM chains. The platform uses a decentralized Relayers Network, consisting of relayer nodes that verify and transfer information across blockchains. This network ensures secure data transfer and enhances security against central points of failure. Relayer nodes must stake SIS tokens to participate in the consensus and process swaps.
Read more on SIS →
